Patents by Inventor Mitchell Dowsett

Mitchell Dowsett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT RESPONSE PREDICTIVE METHOD
    Publication number: 20240052420
    Abstract: The present invention provides a method for predicting whether a human subject having breast cancer will be resistant to, or sensitive to, therapy with a cyclin-dependent kinase (CDK) inhibitor, the method comprising: a) measuring the gene expression in a sample obtained from the breast tumour of the patient to obtain a sample gene expression profile of at least the following modules: (i) a luminal vs.
    Type: Application
    Filed: September 24, 2021
    Publication date: February 15, 2024
    Applicants: The Institute of Cancer Research: Royal Cancer Hospital, Cancer Research Technology Limited, Breast Cancer Now
    Inventors: Mitchell Dowsett, Eugene Francis Schuster, Chon U Maggie Cheang
  • Therapeutic use of piperidine-2,6-diones
    Patent number: 5439921
    Abstract: The use of compounds of formula (I) ##STR1## wherein R represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms and their acid addition salts, for use in the treatment of prostatic cancer or benign prostatic hypertrophy.
    Type: Grant
    Filed: January 6, 1993
    Date of Patent: August 8, 1995
    Assignee: British Technology Group Limited
    Inventor: Mitchell Dowsett